enrasentan has been researched along with atrasentan in 1 studies
| Studies (enrasentan) | Trials (enrasentan) | Recent Studies (post-2010) (enrasentan) | Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) |
|---|---|---|---|---|---|
| 32 | 2 | 0 | 358 | 41 | 108 |
| Protein | Taxonomy | enrasentan (IC50) | atrasentan (IC50) |
|---|---|---|---|
| Endothelin receptor type B | Homo sapiens (human) | 0.2221 | |
| Endothelin-1 receptor | Homo sapiens (human) | 0.0001 | |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | 0.0002 | |
| Endothelin receptor type B | Sus scrofa (pig) | 0.315 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dixon, DB; Jae, HS; Marsh, KC; Nguyen, B; Opgenorth, TJ; von Geldern, TW; Winn, M | 1 |
1 other study(ies) available for enrasentan and atrasentan
| Article | Year |
|---|---|
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 2. Sulfonamide-based ETA/ETB mixed antagonists.
Topics: Administration, Oral; Animals; Atrasentan; Endothelin Receptor Antagonists; Half-Life; Male; Models, Chemical; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Structure-Activity Relationship | 1997 |